Role of inhibitor of yes‐associated protein 1 in triple‐negative breast cancer with taxol‐based chemoresistance-Reference-Cited by-同舟云学术

Role of inhibitor of yes‐associated protein 1 in triple‐negative breast cancer with taxol‐based chemoresistance

Published:2019-01-04 Issue:2 Volume:110 Page:561-567
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Li Ying¹,Wang Shunan²,Wei Xi³^ORCID,Zhang Sheng¹,Song Zian¹,Chen Xiao¹,Zhang Jin¹

Affiliation:

1. The Third Surgical Department of Breast CancerTianjin Medical University Cancer Institute and HospitalNational Clinical Research Center for CancerKey Laboratory of Breast Cancer Prevention and Therapy of Ministry of EducationKey Laboratory of Cancer Prevention and TherapyTianjin's Clinical Research Center for Cancer Tianjin China

2. Department of RadiologyDaping HospitalArmy Medical University Chongqing China

3. Department of Diagnostic and Therapeutic UltrasonographyTianjin Medical University Cancer Institute and HospitalNational Clinical Research Center for CancerKey Laboratory of Cancer Prevention and TherapyTianjin's Clinical Research Center for Cancer Tianjin China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13888

Reference20 articles.

1. Cancer statistics in China, 2015

2. Molecular portraits of human breast tumours;Perou CM;Nature,2000

3. Differential response to primary chemotherapy and long‐term survival in patients with triple‐negative breast cancer;Liedtke C;Eur J Dermatol,2007